Legend Biotech Corporation
Insiders
Last 12 monthsSales planned on beside the trades reported on , and whether each names a .
Planned ·
$10.9M
11 notices · 429,186 sh
Oct 2025 to Oct 2026
Reported ·
$87,139
1 sale · 0 buys
Oct 2025 to Jun 2026
The two figures cover different periods.
The one reported sale does not carry the 10b5-1 box. It is under 0.01% of the shares on issue.
under a no plan named▼ salesize is dollars
Form 144 notices, newest first
2026-09-29Sanders Corazon (Corsee) D., Director$258,915
2026-09-22Santos Carlos E, Chief Financial Officer$50,854
2026-09-22Huang Ying, Chief Executive Officer$1,302,109
2026-06-30Casey Patrick John, Director$88,800
2026-06-26Huang Ying, Chief Executive Officer$79,017
Form 4, 2026-06-29: sold 5,566 at $14.78 Form 4 ↗
2026-03-26Huang Ying, Chief Executive Officer$87,149
2026-03-26Yeung Jessie, Officer$32,663
2025-12-26Huang Ying, Chief Executive Officer$1,449,074
Form 4, 2026-03-27: sold 9,936 at $8.77 Form 4 ↗
2025-12-24Sanders Corazon (Corsee) D., Director$22,064
2025-12-24Huang Ying, Chief Executive Officer$1,410,606
2025-11-17GenScript Corporation, Affiliate$6,166,620